Retrospective cohort study finds early heparin use reduces mortality in cirrhotic patients, suggesting potential benefits.
Early heparin use was associated with reduced 30-day mortality among cirrhotic patients, without increasing the risk of RBC transfusion.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: